Clinical trial Recruiting at 5 sites Interventional Ages 18 to 35 Women only

Evaluating three suturing techniques for closing cesarean incisions

Official title: Niche Investigated: Closure of Hysterotomy & Evaluation of 3 Suturing Techniques (Running, Interrupted, and Locked)

Run by Cairo University · NCT06695793 · Data updated 2026-11-12

This study is testing which of three different stitching methods for closing cesarean incisions helps women heal better and have fewer issues with their scars after surgery.

Quick facts

Study typeInterventional
Ages18 Years to 35 Years
SexWomen only
Enrollment225 (estimated)
SponsorCairo University
Academic / other
Locations5 sites (Cairo and 4 other locations)
StatusRecruiting
StartedNovember 1, 2024
Main results expectedMay 1, 2026
Study endsNovember 1, 2026
Registry record updatedNovember 19, 2024
Trial IDNCT06695793 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women aged 18 to 35 with a singleton pregnancy scheduled for elective cesarean section.

Probably not a fit

Patients with known uterine anomalies, pre-existing medical conditions, or those requiring extensive suturing may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of three different suturing techniques—Running, Interrupted, and Locked—on the formation of a cesarean scar niche in women undergoing elective cesarean sections. The participants will be women with singleton pregnancies, aged 18 to 35, and with a BMI under 30, scheduled for cesarean delivery at 38 to 40 weeks of gestation. The study aims to determine which suturing method may lead to better outcomes in terms of scar formation and healing. Participants will be monitored for their willingness to provide informed consent and meet specific health criteria.

Why it matters

Potential benefit: If successful, this study could lead to improved surgical techniques that minimize complications related to cesarean scars.

How similar studies have gone: While the specific suturing techniques have been explored in various contexts, this study's focus on their impact on cesarean scar niche formation is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Women with a singleton pregnancy scheduled for elective cesarean section
2. Gestational age at the time of cesarean section between 38 and 40 weeks.
3. Willingness to participate in the study and provide informed consent
4. Age between 18 and 35 years old.
5. BMI \<30

Exclusion Criteria:

1. Known uterine anomalies or previous uterine surgery (e.g, myomectomy, uterine septum resection)
2. Pre-existing medical conditions contraindicating cesarean delivery or affecting uterine healing (e.g., Anemia, Diabetes)
3. Current smokers.
4. Non-cephalic presentation of the fetus.
5. Low-lying anterior wall placenta and placenta previa.
6. Inability to provide informed consent (e.g., cognitive impairment, language barrier)
7. Any condition deemed by the attending physician to pose a risk to the participant or compromise the study's integrity, for example, Patients who will require excessive suturing for further hemostasis or those who require ligation of one or both uterine arteries

Where it's running

  • Cairo University
    Cairo, Egypt
    Recruiting
  • Cairo University
    Cairo, Egypt
    Recruiting
  • Cairo University
    Cairo, Egypt
    Recruiting
  • Cairo University
    Cairo, Egypt
    Recruiting
  • Cairo University
    Cairo, Egypt
    Recruiting

Study contacts

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.